Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Kaly Cell

Kaly Cell
2003 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Provider of contract research services with hepatocyte intended to optimize the discovery, development and approval of drugs, food additives, agrochemicals and nutraceuticals. The company's contract research services deliver information to evaluate inter-species differences and inter-individual variations in drug metabolism and safety and adverse reactions, enabling researchers to get information on hepatocyte cell biology, vitro toxicology and cell therapy.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Primary Office
  • 20A rue du Général Leclerc
  • 67115
  • France

+33 03 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Kaly Cell’s full profile, request a free trial.

Kaly Cell Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Kaly Cell Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
SEMIA Incubateur d' Alsace Accelerator/Incubator Minority 000 0000 000000 0

Kaly Cell Executive Team (1)

Name Title Board
Seat
Contact
Info
Lysiane Richert Ph.D Founder, Owner & Scientific Director